BIOREM Reports First Quarter Financial Results and Record $77 Million Order Backlog, Revenue Increase of 44%
Biorem’s $77 million order mountain signals blue-sky demand, but margin clouds linger
On May 14, 2026, Biorem reported first-quarter 2026 results. Revenue jumped 44% year-over-year to $6.82 million, net earnings rose to $201,000 (EPS $0.012), and EBITDA reached $399,000. The standout number is a record order backlog of $77 million as of March 31, 2026, driven by $18.7 million in new bookings from 18 projects across Canada, the U.S., and the Middle East. Cash remains robust at $10 million, with working capital of $14.5 million. However, gross margin slipped to 20% from 23% a year ago, reflecting cost pressures or project mix.
This release signals unambiguous strength in Biorem’s commercial pipeline. The $77 million backlog dwarfs the corrected year-end 2025 figure of $65.3 million and the $54.4 million reported originally for 2025. A single-quarter booking of $18.7 million points to accelerating demand, building on the 32% bookings growth achieved in fiscal 2025. Analysts previously saw the company’s growth trajectory as positive, but the sheer speed of backlog expansion (over 18% in just three months) likely exceeds expectations. The market had already re-rated the shares from ~$2.50 in late Q1 to $3.50 by the eve of the release, so some optimism was priced in. Yet the continued order surge confirms that Biorem’s multi-product, multi-geography strategy is delivering. The margin compression is a caveat, but not enough to derail the thesis given the top-line momentum and robust balance sheet. Therefore, the news qualifies as materially positive — it provides genuinely new evidence of scalable demand that was not fully discounted.
Biorem engineers and manufactures high‑performance air emissions control and odor treatment systems. The company operates a diversified portfolio of technologies applicable to municipal biosolids, industrial processes, and wastewater treatment. Its U.S.-based manufacturing footprint provides tariff mitigation and shortens delivery times for North American clients. Biorem’s flagship “projects” are not a single mine but a constantly rotating suite of custom-engineered installations. The company’s core value proposition lies in multi-product, multi-market resilience.